INS and metabolic disease: Additionally, many patients in the class I and II obesity range (BMI 30–40 kg/m2) in our cohort presented metabolic diseases, likely leading to chronic inflammation, insulin resistance, adipokine dysregulation, and increased production of reactive oxygen species (ROS) [21].